ESEF — Europäische Jahresabschlüsse (iXBRL) fact · point in time
Ascelia Pharma AB: cash_and_equivalents
One fact, its scope and the complete path back to the official record.
Reported value
108.516M{"amount": 108516000.0, "concept": "ifrs-full:CashAndCashEquivalents"}- Entity
- Ascelia Pharma AB
- Metric
- cash_and_equivalents
- Period
- as of 2019-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:5493002YR9VCJJPWYN08:2021-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T01:38:06.089351+02:00
Raw response SHA-256
083ee476e82e5bf5489f72adcba22f97…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.